According to reports, Belanger is a believer in Ocular mainly on the potential of its investigational Axpaxli, a drug that ...

Biologics Licensing Application (BLA) for clemidsogene lanparvovec (RGX-121) submitted and on track for potential FDA approval 2H 2025; strategic partnership with Nippon Shinyaku aims to expand ...

Eye diseases often develop asymptomatically for many years. ICTER scientists have developed the f-ORG technique, which ...

Privately-held Ashvattha Therapeutics, a Californian firm advancing a new class of nanomedicine therapeutics that traverse ...